CD5 and neoplasm: Based on these descriptions, we utilized a similar CD5 depletion strategy to deplete CD5high cells (Fig. 1a-b) from PBMCs obtained from multiple donors including healthy dog volunteers, tumor-bearing dogs, and laboratory beagles.